.png){kind=icon}
返回
Histidinal-Based Potent Antimalarial Agents
.png){kind=icon}
PRE
AI
DOI：10.1002/cmdc.202200709.png)
.png){kind=icon}
原文求助.png){kind=icon}
分享.png){kind=icon}
收藏
摘要
En 中文
Herein we report the synthesis and evaluation of peptide-histidinal conjugated drug scaffolds, which have the potential to target the hemoglobin-degrading proteases falcipain-2/3 from the human malaria parasite. Scaffolds with various substitutions were tested for antimalarial activity, and compounds 8 g, 8 h, and 15 exhibited EC50 values of similar to 0.018 mu M, similar to 0.069 mu M, and similar to 0.02 mu M, respectively. Structure-based docking studies on falcipain-2/3 proteases (PDB:2GHU and PDB:3BWK) revealed that compounds 8 g, 8 h, and 15 interact strongly with binding sites of falcipain-2/3 in a substrate-like manner. In silico ADME studies revealed that the molecules of interest showed no or minimal violations of drug-likeness parameters. Further, phenotypic assays revealed that compound 8 g and its biotinylated version inhibit hemoglobin degradation in the parasite food vacuole. The identification of falcipain-2/3 targeting potent inhibitors of the malaria parasite can serve as a starting point for the development of lead compounds as future antimalarial drug candidates.
Keyword:
P
falciparum
falcipains
chloroquine
artemisinin
docking
digestive vacuole
期刊
IF:
3.4
论文数:
5.1K
被引数:
1.0W
机构
引用论文
Characterization of the exon structure of the Menkes disease gene using vectorette PCR.png)
Genomics
GenomicsIF0
PREAI
分享收藏
Artemisinin-based combination therapies: a vital tool in efforts to eliminate malariaNATURE REVIEWS MICROBIOLOGY
OAAI
NATURE REVIEWS MICROBIOLOGYIF103.3
OAAI分享收藏Antimalarial drug discovery: development of inhibitors of dihydrofolate reductase active in drug resistanceDRUG DISCOVERY TODAY
DRUG DISCOVERY TODAYIF7.5
PREAI
分享收藏
查看更多内容